- Business Wire•18 hours ago
CANCER RESEARCH UK has today announced its first cross-company deal as part of its Experimental Cancer Medicine Centre Combinations Alliance.
- Business Wire•25 days ago
Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the Rodman & Renshaw 18th Annual Global Investment Conference on Tuesday, September 13th at 10:25 AM Eastern Time at The Lotte New York Palace Hotel.
- Associated Press•2 months ago
On a per-share basis, the Needham, Massachusetts-based company said it had a loss of 23 cents. Losses, adjusted for stock option expense, were 18 cents per share. The results exceeded Wall Street expectations. ...
Verastem, Inc. (VSTM)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||1.32 x 500|
|Ask||1.44 x 8000|
|Day's Range||1.33 - 1.39|
|52wk Range||1.05 - 2.43|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.11|
|Avg Vol (3m)||210,723|
|Dividend & Yield||N/A (N/A)|